Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 79, Issue 8, 1997, Pages 1137-1141

  Ino, Toshihiro ^a   Nishimoto, Kei ^a   Okubo, Mataichi ^a   Akimoto, Katsumi ^a   Yabuta, Keijiro ^a   Kawai, Sachio ^a   Okada, Ryozo ^a   Sueyoshi, Noriyoshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; DNA; HYDROXYBUTYRATE DEHYDROGENASE; LACTATE DEHYDROGENASE;

ADOLESCENT; APOPTOSIS; ARTICLE; AUTOPSY; CASE REPORT; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; APOPTOSIS; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FATAL OUTCOME; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031011764     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00066-0     Document Type: Article

References (10)

1. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile in 78 patients. Circulation 1982;67:1388-1394.
2. Spirito P, Chiarella E, Carratio L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-755.
3. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987;60:123-129.
4. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:489-497.
5. James TN, Martin E, Willis PW III, Lohr TO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 1996;93:1424-1438.
6. Fujiwara H, Onodera T, Tanaka M, Shirane H, Kato H, Yoshikawa J, Osakada G, Sasayama S, Kawai C. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J 1984;48:1210-1214.
7. Funakoshi M, Imamura M, Sasaki J, Fujino M, Kawano T, Sasaki Y, Nakashima Y, Motooka T, Fukuda K, Imagawa M, Hiroki T, Arakawa K. Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy. Jpn Heart J 1984;25:805-809.
8. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086-1102.
9. Thierfelder L, Watkins H, WacRae C, Lamas R, McKenna WJ, Vosberg H-P, Seidman JG, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familiar hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-702.
10. Solomon SD, Jarcho JA, MacKenna WJ, Geisterfer-Lowrance A, Germain R, Malerni R, Seidman JG, Seidman CE. Familiar hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 1990;86:993-999.